Radiation Plus Chemo a Good Option in Lung Cancer

Surgery alone not linked to improved survival in non-small-cell lung cancer study MONDAY, July 27 (HealthDay News) -- Radiotherapy plus chemotherapy, with or without surgery, works well for people with stage 3A non-small-cell lung cancer, a new study has found. Stage 3A is declared ...

Gene Can Dampen Chemo Drug Effectiveness

Alternatives to current breast cancer therapy needed for some patients, study says WEDNESDAY, June 10 (HealthDay News) -- Women with a certain type of gene may show marked resistance to an important chemotherapy drug used to treat breast cancer, new research suggests. Scientists at ...

A New Way to Get Chemo to Pancreatic Tumors

Technique that doubles life span in mice may hold hope for people,, THURSDAY, May 21 (HealthDay News) -- Researchers are reporting that they've discovered a way to boost chemotherapy and slightly extend the lives of mice with pancreatic cancer, potentially paving the way for more effec...

Delivering Chemo Directly Into Brain Tumors Shows Promise

Survival times for those with malignant gliomas increased, study found MONDAY, May 4 (HealthDay News) -- Using a catheter to deliver chemotherapy drugs directly into a deadly type of brain tumor is showing promise in early clinical trials, researchers report. Malignant gliomas are d...

Addition of dasatinib to standard chemo cocktail may enhance effect in certain ovarian cancers

DURHAM, N.C. The addition of a chemotherapeutic drug for leukemia to a standard regimen of two other chemotherapy drugs appears to enhance the response of certain ovarian cancers to treatment, according to a pre-clinical study led by researchers in the Duke Comprehensive Cancer Center. "We kn...

Tiny Chemo Beads Boost Liver Cancer Outcomes

They are soaked with drugs to target only the tumor, researchers explain TUESDAY, Jan. 20 (HealthDay News) -- A minimally invasive therapy that uses beads soaked with anti-cancer agents has been successful at halting liver tumors, according to new studies. Transarterial chemoembo...

New Drug May Work Better Against Chemo Side Effects

Japanese testing reveals longer protection from nausea and vomiting THURSDAY, Jan. 8 (HealthDay News) -- A drug that better prevents the nausea and vomiting that commonly follows chemotherapy treatment for cancer may be on the horizon, Japanese researchers report. Studies headed by ...

Higher Chemo Drug Dose Prolongs Lives of Leukemia Patients

Side effects similar to those seen with standard dose of daunorubicin, study shows THURSDAY, Dec. 4 (HealthDay News) -- A high dose of the chemotherapy drug daunorubicin prolonged survival for patients with previously untreated acute myeloid leukemia (AML), preliminary results of a stu...

Avastin Added to Chemo Helps Women With Advanced Breast Cancer

Anti-angiogenesis drug prolonged progression-free survival, study finds SATURDAY, May 31 (HealthDay News) -- Adding the drug Avastin to chemotherapy lengthened progression-free survival in women with advanced breast cancer, new research shows. Previous studies have found that adding...

Erbitux Plus Chemo Improves Lung Cancer Outcomes

Survival extended 5 weeks; benefit seen in all subtypes of disease, researchers say SATURDAY, May 31 (HealthDay News) -- The long-awaited results of a trial of the biologic drug Erbitux on patients with advanced non-small cell lung cancer show it prolonged survival by about five weeks ...

More>>

Chemo in Medical Technology

Alfacell Provides Shareholder Update

...nce with a subgroup of patients who failed a prior chemo therapy. Overall survival was 10.5 months for this...xtend the lives of patients who had failed a prior chemo therapy was not lost in our thoughts. About a yea...strong candidate to be used as an adjunct to other chemo therapy regimes. Of course, our ability to co...

Cancer Treatment Centers of America(R) Studies Treatment That Aims Chemotherapy Directly at Ovarian Cancer Cells

... Therapy targets folate receptors found on cancer cells otherwise resistant to standard chemo ZION, Ill., June 17 /PRNewswire-USNewswire/ -- Cancer Treatment Centers of America (CTCA) at Midwestern Regional Medical Center, a leading pr...

BioVex to Report Phase I/II Clinical Trial Results for the Front Line Treatment of Head and Neck Cancer With OncoVEX GM-CSF at the 2009 American Society of Clinical Oncology Meeting

...ymph nodes in combination with standard first line chemo radiotherapy every three weeks for four cycles. Al... OncoVEX GM-CSF may also allow less aggressive chemo radiation regimens to be employed whilst maintaini...y advanced tumors are best treated with concurrent chemo radiation, with planned neck dissection indicated ...

New Localized Cancer Treatment for Advanced Retinoblastoma Saves Children From Having Eyes Removed, Restores Vision in Some Cases

... Interventional Radiologist Delivers chemo Drug Directly to Eye via Ophthalmic Artery WASHINGTON, March 17 /PRNewswire-USNewswire/ -- A new interventional radiology treatment successfully t...

More>>

Chemo in Medical Dictionary

VDRL

...kind of Doctor to treat the VDRL \n \n what kind of Doctor to treat the VDRL \n Neuroborreliosis is a disorder of the central nervous ... VIDEO: chemo booster cuts treatment time by two months ... VDRL . Definition: VDRL is ascreening test for syphilis that measures antibodies called reagins ....

TIBC

... however, it is also a. negative acute phase reactant. ... Sat (Fe/ TIBC ) (16-60%) Low. Low. m: 16-200 ng/ml. Ferritin. f: 4 ... TIBC . VIDEO: chemo booster cuts treatment time by two months ... TIBC . Definition: ... the total iron binding capacity ( TIBC ) as an indirect measure of transferrin...

Splenomegaly

...ex ... study evaluating splenomegaly in 2056 patients who ... massive splenomegaly , 31% had a hematologic disorder, ... Splenomegaly . VIDEO: chemo booster cuts treatment time by ... Splenomegaly . Definition: Splenomegaly is an enlargement of the spleen beyond its normal size. ... ...

RBC indices

...s are part of the complete blood count (CBC) test. ... These RBC measures are used to diagnose types of anemia. ... RBC indices . VIDEO: chemo booster cuts treatment time by two months ... These RBC indices are useful in the diagnosis of types of anemia. ... RBC indices . Alter...

LH response to GnRH

... response suggests primary gonadal failure (the problem is within ... reduced LH response suggests ... LH response to GnRH . VIDEO: chemo booster cuts treatment time by two months ... LH response to GnRH is a test of the ability of the pituitary gland to ... LH Respons...

Hemolytic crisis

...uction of red blood cells ... A hemolytic crisis causes acute (and often severe) anemia, because the body ... Hemolytic crisis . VIDEO: chemo booster cuts treatment time by two months ... Hemolytic crisis is the rapid destruction of red blood cells (hemolysis) beyond ... Hemolyt...

Hemoglobinopathy

...p of disorders passed down through families inherited ... What is Hemoglobinopathy ? ... Hemoglobinopathy Topic Guide. Advisor. Name ... VIDEO: chemo booster cuts treatment time by two months ... Hemoglobinopathy . Definition: Hemoglobinopathy is a group of rare, inherited disorders involving a...

Endocrine glands

...fects the endocrine glands . ... Endocrine glands are different from other organs in the body because they ... Endocrine glands . VIDEO: chemo booster cuts treatment time by two months ... Endocrine glands . Definition: Endocrine glands produce hormones into the blood or ... E...

Chronic gouty arthritis

...k of acute gouty arthritis . ... Joint x-rays which show damage consistent with gouty arthritis ... Chronic gouty arthritis . VIDEO: chemo booster cuts ... Chronic gouty arthritis . Definition: ... Gout - chronic ; Gouty arthritis - chronic . Text Continues Below ... Learn ...

Breast lump removal

...t and some surrounding tissue from the breast . ... Breast lump removal Health Article. Save Email ... Breast lump removal . VIDEO: chemo booster cuts treatment time by two months ... Breast lump removal . Definition: ... A breast lump may be a solid mass or a ... Breast ...

Chemo in Biological News

Tumor growth and chemo response may be predicted by mathematical model

The aggressiveness of tumors and their susceptibility to chemotherapy may become easier to predict based on a mathematical model developed at The University of Texas Health Science Center at Houston. In spite of extensive experimental and clinical studies, the process of cancer growth is not we...

How chemo kills tumors: research to reduce side effects

University of Manchester researchers are investigating exactly how chemotherapy drugs kill cancerous tumours in a bid to reduce side effects and test the effectiveness of safer new agents. Dr Stephen Taylor and Karen Gascoigne at the University of Manchester's Faculty of Life Sciences have taken...

Herceptin and chemo improves response rates without major adverse effects in HER2 breast cancer

Berlin, Germany: Women with a particularly aggressive form of breast cancer seem to do better if they are treated with a combined anthracycline and taxane chemotherapy regimen before surgery, together with trastuzumab (Herceptin) before and after surgery, according to results from the largest mult...

Standard chemo works better against metastatic BRCA1/2 breast cancer than against sporadic tumors

Berlin, Germany: The first study to investigate the effects of chemotherapy on metastatic breast cancer in women with the BRCA1 or BRCA2 gene mutation has shown that standard chemotherapy works better in these patients than in women without the BRCA1/2 mutation. The authors of a study presente...

Gene thought to assist chemo may help cancer thrive

A gene thought to be essential in helping chemotherapy kill cancer cells, may actually help them thrive. In a new study of chemo patients, scientists at the Georgia Institute of Technology and the Ovarian Cancer Institute found that 70 percent of subjects whose tumors had mutations in the gene p53 ...

Key to lung cancer chemo resistance revealed

Scientists at Johns Hopkins have discovered how taking the brakes off a "detox" gene causes chemotherapy resistance in a common form of lung cancer. Products made by a gene called NRF2 normally protect cells from environmental pollutants like cigarette smoke and diesel exhaust by absorbing the m...

NC State researchers find soy may aid in treating canine cancers

... findings were published in Clinical Cancer Research . "Humans have been using soy in conjunction with traditional chemotherapy for some time as a chemo potentiator," Suter says. "This means that the GCP makes the chemotherapy work more efficiently and faster, which translates to less stress on the pat...

New test for breast cancer will help guide treatment choices

...ce of mind knowing that we're diagnosing cancer more accurately than ever before. We can tell them if they are likely to benefit from chemotherapy. If chemo isn't going to be beneficial, we shouldn't be giving it," Bernard says. The research translates into a simple test that will be available nationwi...

American Chemical Society's weekly PressPac -- Jan. 14, 2009

...ace operations that are ubiquitous in manufacturing, they say. They also say that this demonstration is also a step toward the development of Micro chemo Mechanical Systems (MCMS) in contrast to the already well established field of Micro Electro Mechanical Systems (MEMS); the main difference being that...

Battling bacteria in the blood: Researchers tackle deadly infections

...s patients avoid repeated intravenous needles, it also gives bacteria an easy pathway straight into the blood. Indeed, the mice that received the chemo drug and an injection of bacteria all died of an out-of-control bacterial infection, while mice that didn't receive the drug were able to clear the in...

More>>

Chemo in Biological Technology

Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT-101 in Prostate, Brain, and Lung Cancers at 2009 ASCO Annual Meeting

...received prior platinum-based first line chemotherapy(5). The Phase II portion of the trial included 25 patients divided into chemo-sensitive (A) and chemo refractory (B) cohorts. Median time to progression was 17.4 weeks (range 5.3 - 36.1 weeks) in A and 11.7 weeks (range 1.9 - 19.4 weeks) in B, conside...

3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2008 Results

...inant human thrombopoietin ("TPO") products, continued their rapid uptake trend and are increasingly adopted as the standard of care for chemo Induced Thrombocytopenia. TPIAO net revenue increased 39.7% year-over-year in the fourth quarter of 2008 to RMB16.4 million (US$2.4 mill...

Health Robotics Announces Partnership in the People's Republic of China With The Devon International Group

...ath. While CytoCare(TM) remedies the considerable Chinese-specific problem of retention of child-bearing-age clinicians due to the hazardous nature of chemo IVs, i.v.STATION(TM) solves the IV sterility issues associated with compounding at non-sterile patient care locations. We look forward to officially l...

Minimally Invasive Treatment Offers Hope for Liver Cancer Patients

...oembolization, chemotherapy agents are mixed with embolic particles and are delivered through a catheter directly to the tumor, thereby localizing the chemo treatment" says Phil Scrutton, Analyst at MRG. "The particles also embolize the surrounding arteries, blocking blood flow to the cancerous tissue. Thi...